CAHT provides comprehensive mammalian cell line development services for a variety of biotherapeutic drugs.

We have a professional development team, relying on high yield, fast and stable cell line development platform, can provide customers with stable high quality and expression of stable expression cell lines. From the construction of the vector to the establishment of the cGMP cell bank, we create a complete set of solutions, and according to the regulatory requirements, the production of cell lines and monoclonality are fully documented and traceable, helping customers to speed up the project schedule.